Speaker illustration

Doctor Pablo Garcia-Pavia

Iron Gate Majadahonda University Hospital, Majadahonda (Spain)

Member of:

European Society of Cardiology
Heart Failure Association

Dr García-Pavia is the Head of the Inherited Cardiac Diseases and Heart Failure Unit at the Department of Cardiology of Hospital Universitario Puerta de Hierro in Madrid, Spain. The Inherited cardiac diseases Unit is designed as national (CSUR) and European (ERN) reference unit for inherited cardiovascular diseases . He is also Group Leader at the Spanish National Cardiovascular Research Institute (CNIC). His areas of research include heart failure, amyloidosis and cardiomyopathies. He has published >220 articles in peer-reviewed journals including European Heart Journal, J Am Coll Cardiol, Circulation, Nature Medicine, The Lancet, and The New England Journal of Medicine.

HCM Summit: navigating patient cases

Event: Heart Failure 2024

Topic: Hypertrophic Cardiomyopathy

Session type: Satellite Symposium

Thumbnail

Chronic heart failure - epidemiology, prognosis, outcome 5

Event: Heart Failure 2023

Topic: Epidemiology, Prognosis, Outcome

Session type: Moderated ePosters

Thumbnail

Diagnosing cardiac amyloidosis - Deposit your assumptions at the door!

Event: Heart Failure 2023

Topic: Cardiac Diseases

Session type: Satellite Symposium

Thumbnail

Cardiac imaging in HCM: appropriate use of classic and novel diagnostic tools

Event: EACVI 2023

Topic: Myocardial Disease

Session type: Satellite Symposium

Thumbnail

Idiopathic heart failure or undiagnosed ATTR-CM? Making an early and accurate diagnosis

Event: ESC Congress 2022

Topic: Cardiac Amyloidosis

Session type: Satellite Symposium

Thumbnail

Identifying obstructive HCM: expert perspectives

Event: ESC Congress 2022

Topic: Hypertrophic Cardiomyopathy

Session type: Satellite Symposium

Thumbnail

Highlight on cardiomyopathy

Event: Heart Failure 2022

Topic: Clinical

Session type: Rapid Fire Abstracts

Thumbnail

Faces and Cases: Improving the Management of Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

Event: ESC Congress 2020

Topic: Treatment

Session type: Industry Live

Thumbnail

Expert Advice - Risk prediction for sudden cardiac death in inherited cardiac condition

Event: ESC Congress 2019

Topic: Ion Channel Disorders

Session type: Focus with the Experts

Thumbnail

Novel therapeutic targets in hypertrophic cardiomyopathy

Event: ESC Congress 2019

Topic: Hypertrophic Cardiomyopathy

Session type: Advances in Science

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb